BMS, Ono, and Bayer partner to trial combination therapy for mCRC
BMS’ clinical collaboration with Ono and Bayer will see investigation of combination therapy for metastatic colorectal cancer. Credit: A 4/Flickr.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more